LeonaBio, Inc. (LONA)
NASDAQ: LONA · Real-Time Price · USD
7.69
-0.02 (-0.19%)
At close: Aug 21, 2026, 4:00 PM EDT
7.63
-0.06 (-0.78%)
After-hours: Aug 21, 2026, 7:30 PM EDT
LeonaBio Market Cap
LeonaBio has a market cap or net worth of $72.41 million as of August 21, 2026. Its market cap has increased by 360.70% in one year.
Market Cap
72.41M
Enterprise Value
21.92M
1-Year Change
360.70%
Ranking
Category
Stock Price
$7.69
ChartMarket Cap Chart
Since September 18, 2020, LeonaBio's market cap has decreased from $527.32M to $72.41M, a decrease of -86.27%. That is a compound annual growth rate of -28.47%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 21, 2026 | 72.19M | 141.80% |
| Dec 31, 2025 | 29.86M | 31.60% |
| Dec 31, 2024 | 22.69M | -75.47% |
| Dec 29, 2023 | 92.47M | -22.89% |
| Dec 30, 2022 | 119.92M | -75.36% |
| Dec 31, 2021 | 486.68M | -56.26% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Sep 18, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Gossamer Bio | 75.62M |
| Serina Therapeutics | 72.90M |
| Pliant Therapeutics | 71.52M |
| Spero Therapeutics | 71.05M |
| iBio, Inc. | 71.04M |
| PMV Pharmaceuticals | 70.93M |
| OS Therapies | 70.82M |
| Rein Therapeutics | 69.97M |